What SEC filings are tracked for $PCVX (Vaxcyte, Inc.)?

Position Tracker indexes 1 SEC EDGAR filings for Vaxcyte, Inc. ($PCVX), including 0 Form 10-K annual reports, 0 Form 10-Q quarterly reports, 1 Form 8-K material event disclosures, and 0 Form 4 insider buying and selling filings.

When was the most recent $PCVX (Vaxcyte, Inc.) SEC filing?

The latest tracked SEC EDGAR filing for Vaxcyte, Inc. ($PCVX) was filed on November 4, 2026, with 1 high-impact or featured filings flagged by Position Tracker's AI analysis.

$PCVX SEC EDGAR Filings Hub 1 Filing

$PCVX · Vaxcyte, Inc. SEC Filings

Position Tracker tracks 1 SEC EDGAR filings for Vaxcyte, Inc. ($PCVX) from November 4, 2026 through November 4, 2026, including 0 Form 10-K annual reports, 0 Form 10-Q quarterly earnings reports, 1 Form 8-K current event disclosures, and 0 Form 4 insider equity transactions. Select any filing below to read the full AI summary, key financial takeaways, and original SEC.gov document.

Check $PCVX portfolio concentration → View $PCVX Congress trades → Research $PCVX stock → All SEC filings →

Total Filings1

10-K / 10-Q Reports0

8-K Material Events1

Form 4 Insider0

High-Impact1

Latest FilingNovember 4, 2026

Browse SEC Filings by Form Type

Form 4 Form 8-K Form 10-K Form 10-Q Schedule 13D/13G Form 13F Form S-1 Form 6-K

Latest $PCVX SEC Filings & AI Summaries (1)

$PCVX Form 8-K Impact 8/10 Earnings

November 4, 2026

$PCVX 8-K — Vaxcyte, Inc.

Positive pivotal Phase 3 data for a best-in-class 31-valent pneumococcal vaccine candidate, combined with a $1.1B financing, materially de-risks Vaxcyte's path to a 2028 BLA.

Read AI filing analysis → SEC.gov filing ↗

Related & Peer Company SEC Filing Hubs

$PFE SEC Filings $MRK SEC Filings $STRO SEC Filings

$PCVX · Vaxcyte, Inc. SEC Filings

$PCVX 8-K — Vaxcyte, Inc.

Get real-time alerts when $PCVX files a new 10-K, 10-Q, 8-K, or Form 4.